Search

Your search keyword '"Ostergaard, Lars"' showing total 13 results
Start Over Author "Ostergaard, Lars" Publisher elsevier b.v.
13 results on '"Ostergaard, Lars"'

2. Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology

Author

Lehmann Dahl Pedersen, Anders, Fløe Hvass, Andreas, Yamin Ali Khan, Benjamin, Schiøttz-Christensen, Berit, Cömert, Cagla, Laustsen, Christoffer, Bendstrup, Elisabeth, Wood, Gregory, Erik Bøtker, Hans, Tankisi, Hatice, Andersen, Henning, Agergaard, Jane, Palmfeldt, Johan, Skaalum, Kristoffer, Jørgen Østergaard, Lars, Vibholm, Line, Mølhave, Martin, Katrine Jentoft Olsen, Rikke, Eg Jørgensen, Sofie, Hvitfeldt Poulsen, Steen, Leth, Steffen, Sperling Haugen, Søren, Harbo, Thomas, Mogensen, Trine H., Ullahammer, William, Kim, Won-Yong, Engell-Sørensen, Thomas, Østergaard, Lars, Hejbøl, Eva K., Schrøder, Henrik D., Blicher, Jakob Udby, and Holm Pedersen, Thomas

Published
2023
Full Text
View/download PDF

4. A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR

Author

Coia, John Eugenio, Ellermann-Eriksen, Svend, Friis-Hansen, Lennart, Fuglsang-Damgaard, David, Jarløv, Jens Otto, Jensen, Ulrich Stab, Jespersen, Sanne, Marmolin, Ea Sofie, Nielsen, Lene, Nielsen, Xiaohui Chen, Ramic, Anel, Østergaard, Lars Jørgen, Schneider, Uffe Vest, Forsberg, Maria Wendelboe, Leineweber, Thomas Daell, Jensen, Christel Barker, Ghathian, Khaled, Agergaard, Charlotte Nielsen, Mortensen, Kasper Kjersgaard, Cohen, Arieh, Jørgensen, Charlotte Sværke, Larsen, Helene, Hansen, Matilde Bøgelund, Saleme, Ulla, Koch, Anders, Kirkby, Nikolai Søren, Kallemose, Thomas, Schaadt, Marie Louise, Jensen, Frederikke Holm, Jørgensen, Rikke Lind, Ma, Chih Man German, Steenhard, Nina, Knudsen, Jenny Dahl, and Lisby, Jan Gorm

Published
2022
Full Text
View/download PDF

5. A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology

Author

Prabakaran, Thaneas, Troldborg, Anne, Kumpunya, Sarinya, Alee, Isara, Marinković, Emilija, Windross, Samuel J., Nandakumar, Ramya, Narita, Ryo, Zhang, Bao-cun, Carstensen, Mikkel, Vejvisithsakul, Pichpisith, Marqvorsen, Mikkel H.S., Iversen, Marie B., Holm, Christian K., Østergaard, Lars J., Pedersen, Finn Skou, Pisitkun, Trairak, Behrendt, Rayk, Pisitkun, Prapaporn, and Paludan, Søren R.

Published
2021
Full Text
View/download PDF

9. Etiology of community-acquired pneumonia: evaluation by transtracheal aspiration, blood culture, or serology

Author

Ostergaard, Lars and Andersen, Paul L.

Subjects
Bacterial pneumonia -- Causes of, Serology, Blood -- Analysis and chemistry, Pneumonia -- Causes of, Health, Causes of
Abstract

In a 5-year period, 254 patients with community-acquired pneumonia were attended to. Transtracheal aspiration (TTA) could be performed on 119 patients, blood cultures were performed on 201 patients, and 74 [...]

Published
1993

10. Control of fruit patterning in Arabidopsis by INDEHISCENT

Author

Liljegren, Sarah J., Roeder, Adrienne H.K., Kempin, Sherry A, Gremski, Kristina, Ostergaard, Lars, Yanofsky, Martin F., Reyes, Daengnoy, and Guimil, Soni

Subjects
Protein binding -- Research, Arabidopsis -- Genetic aspects, Genetic research, Biological sciences
Abstract

The seedpod, Arabidopsis opens through a spring loaded mechanism known as pod shatter, which is necessary for dispersal of seeds and INDEHISCENT, an atypical bHLH protein is identified for fruit opening. It was found that FRUITFULL, which is a member of the MADS-domain transcription factor family, is needed for fruit growth.

Published
2004

11. A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults.

Author

Ostergaard, Lars, Lucksinger, Gregg H., Absalon, Judith, Beeslaar, Johannes, Eiden, Joseph, Jansen, Kathrin U., York, Laura J., Quinn, Angela, Graversen, Mette E., and Perez, John L.

Subjects
*MENINGOCOCCAL vaccines, *DISEASES in young adults, *NEISSERIA meningitidis, *COMPLEMENT factor H, *CARRIER proteins, *HEPATITIS A vaccines
Abstract

Background Neisseria meningitidis serogroup B (MnB) is an important cause of invasive meningococcal disease (IMD). A MnB vaccine (bivalent rLP2086, Trumenba ® ) consisting of 2 factor H binding protein variants received accelerated approval in the United States for the prevention of IMD caused by MnB in individuals 10–25 years of age. This randomized, active-controlled, observer-blind study further assessed the safety and tolerability of bivalent rLP2086. Methods Eligible subjects ≥10 to <26 years were randomized (2:1) to receive bivalent rLP2086 at months 0, 2, and 6, or hepatitis A virus vaccine (HAV, Havrix ® ) at months 0 and 6, and saline at month 2. The primary endpoints were serious adverse events (SAEs) throughout the study and medically-attended adverse events (MAEs) within 30 days after vaccination. Additional safety assessments included SAEs at other study intervals and adverse events (AEs) during the vaccination phase. Results Of 5712 subjects randomized, 84.6% ( n = 3219) of bivalent rLP2086 recipients and 87.2% ( n = 1663) of HAV/saline recipients completed the study. Throughout the study, SAEs were reported for 1.6% and 2.5% of bivalent rLP2086 and HAV/saline recipients, respectively. SAEs related to either vaccine were rare. MAEs occurred in 7.0% and 6.1% of subjects after vaccination 1; 5.5% and 6.1% after vaccination 2; and 5.3% and 5.5% after vaccination 3 in the bivalent rLP2086 and HAV/saline groups, respectively. A greater proportion of subjects reported AEs during the vaccination phase after bivalent rLP2086 compared with HAV/saline recipients; however, when reactogenicity events were excluded, the proportion between groups was similar. Conclusion This safety study, the largest randomized, active-controlled trial evaluating a recombinant MnB vaccine, demonstrated that bivalent rLP2086 is safe and tolerable in healthy individuals ≥10 to <26 years of age. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results